Carlos Fernandez-Patron

Summary

Affiliation: University of Alberta
Country: Canada

Publications

  1. ncbi Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis
    Xiang Wang
    Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada
    Hypertension 54:575-82. 2009
  2. ncbi MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE
    Jeffrey Odenbach
    Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Alberta, Canada
    Hypertension 57:123-30. 2011
  3. ncbi Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway
    Li Hao
    Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada
    Circ Res 94:68-76. 2004
  4. ncbi Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis
    Prabhakara Reddy Nagareddy
    Department of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Alberta, Canada T6G 2H7
    Cardiovasc Res 84:368-77. 2009
  5. ncbi Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy
    Xiang Wang
    Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada
    Circulation 119:2480-9. 2009
  6. ncbi Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension
    Ana Lopez-Campistrous
    Department of Biochemistry, Institute for Biomolecular Design, University of Alberta, Edmonton, Alberta, Canada
    Hypertension 51:412-9. 2008
  7. ncbi Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?
    Carlos Fernandez-Patron
    Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada
    Can J Physiol Pharmacol 85:97-104. 2007
  8. ncbi Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species
    Li Hao
    Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
    Arterioscler Thromb Vasc Biol 26:819-25. 2006
  9. ncbi Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease
    Evan Berry
    Department of Biochemistry, School of Translational Medicine, University of Alberta, Edmonton, Alta, Canada
    J Vasc Res 50:52-68. 2013

Collaborators

  • Zamaneh Kassiri
  • Richard Schulz
  • John H McNeill
  • Xiang Wang
  • Li Hao
  • Ana Lopez-Campistrous
  • Jeffrey Odenbach
  • Fung Lan Chow
  • Tatsujiro Oka
  • Evan Berry
  • Stephan Cooper
  • Prabhakara Reddy Nagareddy
  • Gary D Lopaschuk
  • Tamiko Nishimura
  • Ana Maria Bosonea
  • Gary Lopaschuk
  • Kathleen M Macleod
  • Stephan B Cooper
  • Jeff Odenbach
  • Sandra Kelly
  • Barry A Finegan
  • Fung L Chow
  • Dong Ton
  • Michael J Ellison
  • Wang Xiang
  • Joerg Sander
  • Paul Semchuk
  • Hua Wo
  • Min Du

Detail Information

Publications9

  1. ncbi Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis
    Xiang Wang
    Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada
    Hypertension 54:575-82. 2009
    ..Targeting TACE has potential therapeutic importance for modulating agonist-induced cardiac remodeling...
  2. ncbi MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE
    Jeffrey Odenbach
    Department of Biochemistry, School of Molecular and Systems Medicine, University of Alberta, Edmonton, Alberta, Canada
    Hypertension 57:123-30. 2011
    ..This suggests a functional specialization of MMP-2 in agonist-induced cardiovascular disease development that has potential implications for the design of metalloproteinase-based therapeutic strategies...
  3. ncbi Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway
    Li Hao
    Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada
    Circ Res 94:68-76. 2004
    ..Because this mechanism is triggered by agonists typically overexpressed in hypertension, its blockade may have therapeutic potential for simultaneously inhibiting pathological vasoconstriction and growth in hypertensive disorders...
  4. ncbi Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesis
    Prabhakara Reddy Nagareddy
    Department of Biochemistry, Faculty of Medicine and Dentistry, University of Alberta, Alberta, Canada T6G 2H7
    Cardiovasc Res 84:368-77. 2009
    ..In the present study, we examined whether MMP modulation of vascular tone involves phosphoinositide 3-kinase (PI3K) and mitochondrial ATP synthesis...
  5. ncbi Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy
    Xiang Wang
    Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada
    Circulation 119:2480-9. 2009
    ..Here, we report that matrix metalloproteinase-7 (MMP-7) and a disintegrin and metalloproteinase-12 (ADAM-12) form a novel signaling axis in these processes...
  6. ncbi Mitochondrial dysfunction in the hypertensive rat brain: respiratory complexes exhibit assembly defects in hypertension
    Ana Lopez-Campistrous
    Department of Biochemistry, Institute for Biomolecular Design, University of Alberta, Edmonton, Alberta, Canada
    Hypertension 51:412-9. 2008
    ..This mitochondrial dysfunction localizes to the brain stem and is, therefore, likely to contribute to the development, as well as to pathophysiological complications, of hypertension...
  7. ncbi Therapeutic potential of the epidermal growth factor receptor transactivation in hypertension: a convergent signaling pathway of vascular tone, oxidative stress, and hypertrophic growth downstream of vasoactive G-protein-coupled receptors?
    Carlos Fernandez-Patron
    Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada
    Can J Physiol Pharmacol 85:97-104. 2007
    ..If this hypothesis is proven generally correct, then transactivation blockers have general therapeutic potential in hypertension regardless of the causative agonist...
  8. ncbi Vascular responses to alpha1-adrenergic receptors in small rat mesenteric arteries depend on mitochondrial reactive oxygen species
    Li Hao
    Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada
    Arterioscler Thromb Vasc Biol 26:819-25. 2006
    ....
  9. ncbi Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease
    Evan Berry
    Department of Biochemistry, School of Translational Medicine, University of Alberta, Edmonton, Alta, Canada
    J Vasc Res 50:52-68. 2013
    ..The emerging links between metalloproteinases and lipids are intriguing and suggest new therapeutic targets in hypertensive cardiac disease...